4basebio PLC (LON:4BB - Get Free Report) insider Heikki Lanckriet bought 2,400 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The shares were purchased at an average price of GBX 1,205 ($15.54) per share, with a total value of £28,920 ($37,306.50).
4basebio Stock Performance
Shares of LON:4BB opened at GBX 1,205 ($15.54) on Friday. The business has a fifty day moving average of GBX 1,142.07 and a 200-day moving average of GBX 1,232.05. The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. 4basebio PLC has a twelve month low of GBX 901 ($11.62) and a twelve month high of GBX 1,820 ($23.48). The firm has a market cap of £154.36 million, a PE ratio of -1,544.87 and a beta of 1.09.
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada reiterated an "outperform" rating and issued a GBX 1,600 ($20.64) target price on shares of 4basebio in a research note on Thursday, March 13th.
Read Our Latest Analysis on 4BB
4basebio Company Profile
(
Get Free Report)
4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.
Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
